MEDICINOVA INC (MNOV) Stock Analyst Ratings
NASDAQ:MNOV - Nasdaq - US58468P2065 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to MNOV. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.14. This target is 462.29% above the current price.
MNOV was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MNOV.
In the previous month the buy percentage consensus was at a similar level.
MNOV was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-06-16 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-04-09 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-14 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-06 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-02 | D. Boral Capital | Initiate | Buy |
| 2021-03-10 | Maxim Group | Initiate | Buy |